•Intended to be used for ex vivo preparation of apheresis platelet components in order to reduce the risk of transfusion-transmitted infection (TTI) including sepsis, and to potentially reduce the risk of transfusion-associated graft versus host disease (TA-GVHD).
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/IebaDhZ
No comments:
Post a Comment